Alzheimer’s-focused Foster City biotech TrueBinding raises $100M


The company in May said it had completed recruitment of 140 mild to severe Alzheimer's patients for a mid-stage clinical trial.

Previous Novavax receives order from U.S. for 3.2M doses of its Covid vaccine
Next The Salty Donut is coming to Tampa